ArticleNature communications2026

CD73 disruption with tumor-specific CRISPR/Cas9 nanoparticles reduces adenosine-mediated immunosuppression and amplifies response to chemotherapy.

Xinhong Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.